JOURNAL BROWSE
Search
Advanced SearchSearch Tips
FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance
Malak, Camelia A Abdel; Elghanam, Doaa M; Elbossaty, Walaa Fikry;
  PDF(new window)
 Abstract
Background: To investigate the expression of the fragile histidine triad (FHIT) gene in acute lymphoblastic leukemia and its clinical significance. Materials and Methods: The level of expressed FHIT mRNA in peripheral blood from 50 patients with acute lymphoblastic leukemia (ALL) and in 50 peripheral blood samples from healthy volunteers was measured via RT-PCR. Correlation analyses between FHIT gene expression and clinical characteristics (gender, age, white blood count, immunophenotype of acute lymphoblastic leukemia and percentage of blast cells) of the patients were performed. Results: The FHIT gene was expressed at of ALL patients against in the healthy volunteers. The difference in the expression levels between ALL patients and healthy volunteers was statistically significant. The rate of gene expression did not significantly vary with immunophenotype subtypes. Gene expression was also found to be correlated with increase of total leukocyte and decrease in platelets, but not with age, gender, immunophenotyping or percentage of blast cells. Conclusions: FHIT gene expression is low in acute lymphoblastic leukemia and could be a useful marker to monitor minimal residual disease. This gene is also a candidate target for the immunotherapy of acute lymphoblastic leukemia.
 Keywords
FHIT gene;acute lymphoblastic leukemia;immunotherapy;tumor suppressor gene;
 Language
English
 Cited by
 References
1.
Alison Walker and Guido Marcucci (2012). Molecular prognostic factors in cytogenetically normal acute myeloid leukemia. Expert Rev Hematol, 5, 547-58. crossref(new window)

2.
Chen Xu, Hui Zhang, Ping Li, et al (2013). Gene expression of WWOX, FHIT and p73 in acute lymphoblastic leukemia. Oncology Letters, 6, 963-9. crossref(new window)

3.
Cobaleda C, Sanchez Garcia I (2009). B-cell acute lymphoblastic leukaemia: Towards understanding its cellular origin. Bioessays, 31, 600-609. crossref(new window)

4.
Gemma Toledo, Jesus Javier Sola, Maria Dolores Lozano, et al (2004). Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Modern Pathology, 17, 440-8 crossref(new window)

5.
Gokbuget N, Hoelzer D (2009). Treatment of adult acute lymphoblastic Leukemia. Semin Hematol, 46, 64-75. crossref(new window)

6.
Gomes AM, Soares MV, Ribeiro P, et al (2014). Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and Constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels. Haematologica, 99, 1062-8 crossref(new window)

7.
Hagop M. Kantarjian, Moshe Talpaz, Susan O'Brien, et al (1999). Significance of FHIT expression in chronic myelogenous leukemia. Clinical Cancer Research, 4059, 4059-64.

8.
Hallas C, Albitar M, Letofsky J, etal (1999). Loss of FHIT expression in acute lymphoblastic leukemia. Cin Cancer Res, 5, 2409-14.

9.
Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real- time quantitative PCR and the 2(-Delta Delta CT) method. Methods, 25, 402-8 crossref(new window)

10.
Marks DI (2010). Treating the "older" adult with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program, 13-20.

11.
Mona M. Taalab, Iman M. Fawzy, Enas F. Gouda, etal (2014). BAALC gene expression in adult b-precursor acute lymphoblastic leukemia: impact on prognosis. J Blood Disorders Transf, 5.

12.
Shichun Zheng, Xiaomei Ma, Luoping Zhang, et al (2004). Hypermethylation of the 5_ CpG Island of the FHIT Gene Is Associated with Hyperdiploid and Translocation-Negative Subtypes of Pediatric Leukemia. Cancer Research, 64, 2000-6 crossref(new window)

13.
Wang HL, Zhou PY, Liu P, et al (2014). Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis. Tumour Biol, 35, 6815-21 crossref(new window)

14.
Waters C, Saldivar J, Hosseini SA, et al (2014). The FHIT gene product: tumor suppressor and genome “caretaker”. Cell Mol Life Sci, 71, 4577-87 crossref(new window)

15.
Zhiwei Chang, Weijie Zhang, Zhijun Chang, et al (2015). Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer. Oncology Letters, 9, 430-6 crossref(new window)

16.
Zhou Y, Slack R, Jorgensen JL, et al (2014). The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk, 14, 319-26 crossref(new window)